IMA

NASD ImageneBio, Inc.
Oct 16, 2026 · 1:21 AM ET EOD Market Closed

$4.03 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.03, $0.23 below the day’s high of $4.26

YTD change
-41.59%
vs 20-day SMA
-12.22%
vs 200-day SMA
-30.42%

Price ranges

Previous day
$4.14 $4.20
open $4.20 close $4.15
-$0.05 (-1.18%)
Today
$3.98 $4.26
open $4.15 now $4.03
-$0.12 (-2.89%)
Past week
$3.90 $4.61
from $4.61 now $4.03
-$0.58 (-12.58%)
Past month
$3.90 $5.28
from $4.93 now $4.03
-$0.90 (-18.26%)
This year
$3.90 $7.60
from $6.90 now $4.03
-$2.87 (-41.59%)

Price & Performance

-1.62 (-28.67%) / 6M

$3.86$4.67$5.47$6.28Apr 15Jul 16Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 77.6% away from all-time highs of $18.00
  • IMA is down 42% since the beginning of the year
  • IMA is down 47% over the past 12 months
  • IMA is down 18% over the past 1 month
  • 0% of all IMA investors are betting against IMA

IMA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -47.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.63
Earnings momentum +21.7% Quarterly EPS growth
Quarterly change +21.7%

Valuation

P/E ratio N/A
Enterprise value $-64601800.0
Beta 0.62

Balance sheet & scale

IncomeN/A
Revenue$800.0K
Cash$136.2M
Debt$4.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $66.2M

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $434.03 +1.86%
MRNA Moderna, Inc. $236.50 +4.51%
RVMD Revolution Medicines, Inc. $189.26 -2.20%
ROIV Roivant Sciences Ltd. $34.04 +1.25%
BNTX BioNTech SE Sponsored ADR $90.20 +1.74%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.